193 related articles for article (PubMed ID: 1596884)
1. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.
Nierodzik ML; Kajumo F; Karpatkin S
Cancer Res; 1992 Jun; 52(12):3267-72. PubMed ID: 1596884
[TBL] [Abstract][Full Text] [Related]
2. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.
Nierodzik ML; Plotkin A; Kajumo F; Karpatkin S
J Clin Invest; 1991 Jan; 87(1):229-36. PubMed ID: 1845869
[TBL] [Abstract][Full Text] [Related]
3. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
Nierodzik ML; Klepfish A; Karpatkin S
Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
5. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
Karpatkin S; Pearlstein E; Ambrogio C; Coller BS
J Clin Invest; 1988 Apr; 81(4):1012-9. PubMed ID: 3280598
[TBL] [Abstract][Full Text] [Related]
6. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model.
Beviglia L; Stewart GJ; Niewiarowski S
Oncol Res; 1995; 7(1):7-20. PubMed ID: 7549046
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C.
Dumont JA; Jones WD; Bitonti AJ
Cancer Res; 1992 Mar; 52(5):1195-200. PubMed ID: 1737379
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
9. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions.
Chopra H; Fligiel SE; Hatfield JS; Nelson KK; Diglio CA; Taylor JD; Honn KV
Cancer Res; 1990 Dec; 50(23):7686-96. PubMed ID: 2253213
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells.
Karpatkin S; Ambrogio C; Pearlstein E
Cancer Res; 1984 Sep; 44(9):3880-3. PubMed ID: 6378376
[TBL] [Abstract][Full Text] [Related]
11. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.
Amirkhosravi A; Amaya M; Siddiqui F; Biggerstaff JP; Meyer TV; Francis JL
Platelets; 1999; 10(5):285-92. PubMed ID: 16801104
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
13. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
14. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
Fuster MM; Brown JR; Wang L; Esko JD
Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
[TBL] [Abstract][Full Text] [Related]
15. Role of von Willebrand factor in tumor metastasis.
Terraube V; Marx I; Denis CV
Thromb Res; 2007; 120 Suppl 2():S64-70. PubMed ID: 18023715
[TBL] [Abstract][Full Text] [Related]
16. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
[TBL] [Abstract][Full Text] [Related]
17. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
Kim HA; Ko HM; Ju HW; Kim KJ; Roh SG; Lee HK; Im SY
Cancer Lett; 2009 Feb; 274(1):160-4. PubMed ID: 18952369
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet integrin GPIIb-GPIIIa, fibronectin, von Willebrand factor, and thrombin in platelet-tumor interaction in vitro and metastasis in vivo.
Nierodzik ML; Klepfish A; Karpatkin S
Semin Hematol; 1994 Oct; 31(4):278-88. PubMed ID: 7831573
[No Abstract] [Full Text] [Related]
19. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
20. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
Tang DG; Diglio CA; Honn KV
Cancer Res; 1994 Feb; 54(4):1119-29. PubMed ID: 8313370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
